This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 31 May 2013  |  Europe

    Global Point-of-Care Testing (POCT) Market

    Increasing Adoption of POCT in Emerging Countries will Provide Impetus to Market Growth

    Reduced turnaround time and potential benefits of immediate diagnosis have resulted in an increased adoption of POCT in hospitals and physician office laboratories. However, whether POC tests replace traditional laboratory tests is a question still being debated in the scientific community. This study provides the market overview, market engineerin...

    $4,950.00
  2. 06 May 2013  |  Europe

    Healthcare Landscape and Outlook in Turkey

    Top Growth Opportunities by 2015

    The study analyses the Turkish healthcare landscape, market outlook and growth opportunities by covering private healthcare services, pharmaceuticals, medical devices, medical imaging and clinical diagnostics segments. Rapid economic growth and healthcare transformation program generated a significant increase in healthcare expenditure in Turkey. T...

    $4,950.00
  3. 05 Apr 2013  |  Europe

    Market Trends in Interventional Radiology and Cardiology in Europe

    The Future is in Hybrid Systems

    This research service provides an analysis of various aspects of the interventional radiology and cardiology market in Europe between 2011 and 2017. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, Scandinavia, Spain and the United Kingdom. A detailed analysis of...

    $4,950.00
  4. 19 Mar 2013  |  Europe

    A Product and Pipeline Analysis of the Global Haematology Therapeutics Market

    An Overview of Promising Drugs and Innovations in the Haematology Therapeutics Market

    This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, ...

    $1,500.00
  5. 12 Mar 2013  |  Europe

    Effective Strategies to Overcome Challenges Faced by Global Generic Drug Makers

    Challenges Confronting Global Generic Drug Manufacturers

    This article explains in detail the various challenges that confront the generic drug manufacturers in the global generic pharmaceuticals market. The defense strategies adopted by branded pharmaceutical companies to delay generic versions of their products have also been discussed. Strategic recommendations for the success of global generic compani...

    $1,500.00
  6. 28 Feb 2013  |  Europe

    Image-Guided and Robot-Assisted Surgery Market in Western Europe

    Market Grows Despite Skepticism Over Proven Advantages of Robotics

    The research service examines the image-guided and robot-assisted surgery market in Western Europe, covering the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The analysis includes market dynamics, revenue forecasts, market share, and competitive structure. The market has been segmented as: surgical imaging systems (SIS),...

    $4,950.00
  7. 22 Feb 2013  |  Europe

    Human Growth Hormones: Product Differentiation to Play a Vital Role in Europe

    Technology Innovation and Product Differentiation Are Crucial for Increasing Market Shares

    This market insight provides a detialed explaination of the key challenges confronting existing industry participants and deterring new entrants in the European human growth hormones market. The key product differentiation strategies adopted by companies have been highlighted and discussed in depth with examples.

    $1,500.00
  8. 20 Feb 2013  |  Europe

    Western and Eastern European Markets for Computed and Digital Radiography

    Retrofit Systems are Expected to Boost Market Growth

    This research service analyses various aspects of the computed and digital radiography market in Europe between 2010 and 2016. The market is divided into two segments: computed radiography and digital radiography. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, ...

    $4,950.00
  9. 13 Feb 2013  |  Europe

    Unlocking the Mystery of Alzheimers Disease: Controversies over Hypotheses

    Struggling Search for the Best Disease-modifying Approach

    This market insight compares and contrasts the various hypotheses postulated based on Alzheimers disease-modifying drug candidates under investigation in clinical trials. The mechanisms based on the two hallmark features of the disease, namely beta-amyloid and tau protein, have been analysed in detail. A brief overview of the other range of disease...

    $1,500.00
  10. 27 Sep 2012  |  Europe

    European Alzheimers Disease Medication Market

    Launch of Disease-modifying Drugs expected to Boost Market Growth

    The key objective of this research service  is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments.  It also aims...

    $4,950.00